
Aquastar (USA) Corp Recalls Shrimp Because Of Possible Health Risk
COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.
Read Announcement View Product Photos Summary Company Announcement Date: October 17, 2025 FDA Publish Date: October 17, 2025 Product Type: Food & BeveragesShellfish
Foodborne Illness Reason for Announcement:
Recall Reason Description
Product may have been prepared, packed, or held under conditions whereby they may have become exposed to very low levels of cesium-137 (Cs-137)
Company Name: AquaStar Corp Brand Name:Brand Name(s)
AquaStar, Best Yet, Waterfront Bistro, Publix
Product Description:Product Description
Company AnnouncementOctober 17, 2025, AquaStar (USA) Corp of Seattle, WA is voluntarily recalling a limited quantity of frozen shrimp imported from Indonesia because they may have been prepared, packed, or held under conditions whereby they may have become exposed to very low levels of cesium-137 (Cs-137).
None of the aforementioned or below listed product ever tested positive for Cs-137.
No illnesses have been reported to date and this recall is only being issued out of a preponderance of caution.
This recall is being made with the knowledge of the U.S. Food and Drug Administration.
Consumers who have purchased affected shrimp should not consume the product and should dispose of or return it to the place of purchase for a full refund.
Cs-137 is a man-made radioisotope of cesium. Traces of Cs-137 are widespread in the environment and can be present in the environment at background levels, and at higher levels in water or foods grown, raised, or produced in areas with environmental contamination.
Consumers with questions may contact AquaStar at 1-800-331-3440.
Product Images
FDA Outbreak Advisory
Company Contact Information Consumers: AquaStar 1-800-331-3440Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- Ethereum Startup Agoralend Opens Fresh Fundraise After Oversubscribed $300,000 Round.
- KOR Closes Series B Funding To Accelerate Global Growth
- Wise Wolves Corporation Launches Unified Brand To Power The Next Era Of Cross-Border Finance
- Lombard And Story Partner To Revolutionize Creator Economy Via Bitcoin-Backed Infrastructure
- FBS AI Assistant Helps Traders Skip Market Noise And Focus On Strategy
Comments
No comment